Stay updated on Fazirsiran Safety & Efficacy Clinical Trial
Sign up to get notified when there's something new on the Fazirsiran Safety & Efficacy Clinical Trial page.
Latest updates to the Fazirsiran Safety & Efficacy Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.1%
- Check20 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study, along with the study's location.SummaryDifference2%
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedSeveral key resources related to alpha-1 antitrypsin deficiency have been removed, including links to MedlinePlus and NIH, which may impact access to important genetic and health information.SummaryDifference4%
- Check41 days agoChange DetectedThe website has been updated to version 2.12.2, with new resources added related to alpha-1 antitrypsin deficiency, including links to MedlinePlus and NIH, while the previous version 2.12.1 has been removed.SummaryDifference4%
- Check56 days agoChange DetectedThe website has been updated from version 2.12.0 to 2.12.1.SummaryDifference0.1%
- Check63 days agoChange DetectedThe website has updated to version v2.12.0, adding 'Results Submitted' while removing 'No Results Posted' from the previous version v2.11.2.SummaryDifference0.2%
Stay in the know with updates to Fazirsiran Safety & Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fazirsiran Safety & Efficacy Clinical Trial page.